Tibbitts Gregory J — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Tibbitts Gregory J is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
In SEC filing contexts, the individual appears as Tibbitts Gregory J, which corresponds to Gregory J. Tibbitts. He is identified as a Director of Mainz Biomed N.V., a biotech company focused on colorectal cancer early detection. The 2026-02-19 SEC filing confirms his role on Mainz Biomed's board. Beyond this filing, publicly available biographical details (education, career history, other roles) are not provided in the context here. As a board director, he would be involved in governance and oversight of Mainz Biomed N.V.'s strategy and financial reporting.
Role
Director
Notability
40/100
Board memberships
Mainz Biomed N.V.
Awards & honors
Listed as a Director on Mainz Biomed N.V.'s SEC filings as of 2026-02-19
In SEC filing contexts, the individual appears as Tibbitts Gregory J, which corresponds to Gregory J. Tibbitts. He is identified as a Director of Mainz Biomed N.V., a biotech company focused on colorectal cancer early detection. The 2026-02-19 SEC filing confirms his role on Mainz Biomed's board. Beyond this filing, publicly available biographical details (education, career his…
Where can I see all of Tibbitts Gregory J's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
